english.prescrire.org > Spotlight > Archives : 2026 > Dexamfetamine (Tentin°) or lisdexamfetamine (Xurta°) in attention deficit hyperactivity disorder

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

Dexamfetamine (Tentin°) or lisdexamfetamine (Xurta°) in attention deficit hyperactivity disorder

 Marketing Authorisations  The known risks of amphetamines, and inadequate clinical evaluation.
Full article available for download by subscribers

 ©Prescrire 1 May 2026

Source: "Dexamfetamine (Tentin°) or lisdexamfetamine (Xurta°) in attention deficit hyperactivity disorder" Prescrire Int 2026; 35 (281): 117-121. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook  
 
 
See also:
 
"Methylphenidate:
the youngest children
in a given school year
at higher risk of starting
treatment"
Prescrire Int 2026;
35 (277): 26.
Subscribers only